Action IMCD NV - IMCD

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

137,40

Prix Achat

135,00

Prix Vente

138,25

Volume échangé

156 896

134,10 Fourchette du Jour 137,45

126,65 Plage de 52 semaines 169,05

Cap du marché

7,83B

Clôture Veille

136,55

Ouverture

135,95

Dernière Transaction

137.4

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

95 467

Actions en circulation

56 988 000

Rendement du Dividende

Ratio Cours sur Bénéfices

26,79

Bénéfice par action (BPA)

5,13

Chiffre d'affairess

4,47B

Bénéfice net

292,27M

Secteur

Chemicals & Chem Preps, Nec

Industrie

Chemicals & Chem Preps, Nec

Site Web

www.imcdgroup.com

Siège social

Rotterdam, South Holland, Nld

Fondé

IMCD NV est coté dans le secteur Chemicals & Chem Preps de la Euronext avec le ticker IMCD. Le dernier cours de clôture d'IMCD NV était de 136,55 €. Au cours de la dernière année, les actions de IMCD NV ont été négociées dans une fourchette de prix de 126,65 € à 169,05 €.

IMCD NV compte actuellement 56 988 000 actions en circulation. La capitalisation boursière d'IMCD NV est de 7,78 € milliard. IMCD NV a un ratio cours/bénéfice (ratio PE) de 26.79.

IMCD reports EBITA growth to EUR 531 million in 2024

IMCD reports EBITA growth to EUR 531 million in 2024 Rotterdam, The Netherlands (5 March 2025) - IMCD N.V. (“IMCD” or “Company”), a global leading...

IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets

IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets ROTTERDAM, The Netherlands (3 March 2025) –...

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets ROTTERDAM, The...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-5.1	-3.57894736842	142.5	147.25	132.55	181017	140.40711264	DE
4	-14.15	-9.33685252392	151.55	155.4	132.55	119218	145.87876636	DE
12	-11.4	-7.66129032258	148.8	155.4	132.55	95467	144.52649681	DE
26	-11.45	-7.69230769231	148.85	159	132.55	88653	146.73000999	DE
52	-19.05	-12.1764141898	156.45	169.05	126.65	94887	145.30444878	DE
156	3.35	2.49906751212	134.05	169.05	107.6	113964	139.90330215	DE
260	69.85	103.40488527	67.55	211.3	51.65	128770	133.03908544	DE

IMCD - Frequently Asked Questions (FAQ)

What is the current IMCD NV share price?

The current share price of IMCD NV is 137,40 €

How many IMCD NV shares are in issue?

IMCD NV has 56 988 000 shares in issue

What is the market cap of IMCD NV?

The market capitalisation of IMCD NV is EUR 7,78B

What is the 1 year trading range for IMCD NV share price?

IMCD NV has traded in the range of 126,65 € to 169,05 € during the past year

What is the PE ratio of IMCD NV?

The price to earnings ratio of IMCD NV is 26,79

What is the cash to sales ratio of IMCD NV?

The cash to sales ratio of IMCD NV is 1,75

What is the reporting currency for IMCD NV?

IMCD NV reports financial results in EUR

What is the latest annual turnover for IMCD NV?

The latest annual turnover of IMCD NV is EUR 4,47B

What is the latest annual profit for IMCD NV?

The latest annual profit of IMCD NV is EUR 292,27M

What is the registered address of IMCD NV?

The registered address for IMCD NV is WILHELMINAPLEIN 32, ROTTERDAM, SOUTH HOLLAND, 3072 DE

What is the IMCD NV website address?

The website address for IMCD NV is www.imcdgroup.com

Which industry sector does IMCD NV operate in?

IMCD NV operates in the CHEMICALS & CHEM PREPS, NEC sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ALEUPEuroplasma	0,02 € (78,57%)	365,72M
MLAZRThe Azur Selection SA	1,13 € (61,43%)	47,07k
ALCYBCybergun	0,0003 € (50,00%)	4,22B
ALJXRArchos	0,241 € (37,71%)	10,35M
ALDOLDolfines	3,21 € (29,96%)	118,41k
DMSBSDiagnostic Medical Systems	0,0015 € (-81,25%)	14,15k
BNBSTonner Drones	0,002 € (-42,86%)	1,61M
TDBSTonner Drones	0,0038 € (-41,54%)	23,76M
BUIBarbara Bui	3,10 € (-24,39%)	1,05k
MLTROTroc de l Ile	2,50 € (-20,38%)	60
ATOAtos SE	0,0046 € (-6,12%)	5,99B
ALCYBCybergun	0,0003 € (50,00%)	4,22B
ALEUPEuroplasma	0,02 € (78,57%)	365,72M
ALTDTonner Drones	0,027 € (-20,12%)	282,8M
BCPBanco Comercial Portugues SA	0,5538 € (2,44%)	91,6M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

IMCD NV (IMCD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de IMCD NV

IMCD Dernières nouvelles

IMCD reports EBITA growth to EUR 531 million in 2024

IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD China strengthens its life science business with the acquisition of Daoqin

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD reports EBITA of EUR 403 million in the first nine months of 2024

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

IMCD successfully issues a EUR 500 million rated bond

IMCD reports EBITA of EUR 270 million in the first half of 2024

IMCD reports EBITA growth to EUR 531 million in 2024

IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD China strengthens its life science business with the acquisition of Daoqin

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD reports EBITA of EUR 403 million in the first nine months of 2024

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

IMCD - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

IMCD NV (IMCD) Cours

IMCD NV (IMCD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de IMCD NV

IMCD Dernières nouvelles

IMCD reports EBITA growth to EUR 531 million in 2024

IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD China strengthens its life science business with the acquisition of Daoqin

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD reports EBITA of EUR 403 million in the first nine months of 2024

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

IMCD successfully issues a EUR 500 million rated bond

IMCD reports EBITA of EUR 270 million in the first half of 2024

IMCD reports EBITA growth to EUR 531 million in 2024

IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets

IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets

IMCD China strengthens its life science business with the acquisition of Daoqin

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD reports EBITA of EUR 403 million in the first nine months of 2024

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

IMCD - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités